Tyrvaya
Payments companies reported to CMS as associated with Tyrvaya. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tyrvaya, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tyrvaya
These are the largest totals companies reported as associated with Tyrvaya. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Richard Adler | Baltimore, MD | Ophthalmology | $121,383.44 |
| Francis Mah | Pittsburgh, PA | $103,029.02 | |
| Rolando Toyos | Memphis, TN | Ophthalmology | $93,075.47 |
| Ravi Patel | Eatontown, NJ | Ophthalmology | $65,039.66 |
| Douglas Devries | Sparks, NV | Optometrist | $64,774.85 |
| Mark Milner | Palm Beach Gardens, FL | Ophthalmology | $63,991.02 |
| Pamela Theriot | Shreveport, LA | Optometrist | $63,166.13 |
| Sheri Rowen | Newport Beach, CA | Ophthalmology | $62,243.35 |
| Damon Dierker | Indianapolis, IN | Optometrist | $60,105.36 |
| Jessica Steen | Davie, FL | Optometrist | $58,677.47 |
Prescribed Tyrvaya?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.